Effects of bisphenol A and its chemical analogues on the microenvironment and female breast cancer development (Review)
- Authors:
- Shreeja Tripathi
- Katharina Kusserow
- Kerri Palmer
- Abigail Dodson
- Dylan Peter Mcclurg
- Valerie Speirs
-
Affiliations: School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK - Published online on: May 26, 2025 https://doi.org/10.3892/wasj.2025.354
- Article Number: 66
-
Copyright : © Tripathi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lippman ME, Krueger KA, Eckert S, Sashegyi A, Walls EL, Jamal S, Cauley JA and Cummings SR: Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol. 19:3111–3116. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Nguyen B, Venet D, Lambertini M, Desmedt C, Salgado R, Horlings HM, Rothé F and Sotiriou C: Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer. Breast Cancer Res. 21(25)2019.PubMed/NCBI View Article : Google Scholar | |
|
Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ and Paterson AD: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 6:798–808. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Perou CM, Sørile T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al: Molecular portraits of human breast tumours. Nature. 406:747–752. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Pareja F, Geyer FC, Marchiò C, Burke KA, Weigelt B and Reis-Filho JS: Triple-negative breast cancer: The importance of molecular and histologic subtyping, and recognition of low-grade variants. NPJ Breast Cancer. 2(16036)2016.PubMed/NCBI View Article : Google Scholar | |
|
Soysal SD, Tzankov A and Muenst SE: Role of the tumor microenvironment in breast cancer. Pathobiology. 82:142–152. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Terceiro LEL, Edechi CA, Ikeogu NM, Nickel BE, Hombach-Klonisch S, Sharif T, Leygue E and Myal Y: The breast tumor microenvironment: A key player in metastatic spread. Cancers (Basel). 13(4798)2021.PubMed/NCBI View Article : Google Scholar | |
|
Weigelt B and Bissell MJ: Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol. 18:311–321. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Mittal S, Brown NJ and Holen I: The breast tumor microenvironment: Role in cancer development, progression and response to therapy. Expert Rev Mol Diagn. 18:227–243. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT and Gore AC: Endocrine-disrupting chemicals: An endocrine society scientific statement. Endocr Rev. 30:293–342. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Yilmaz B, Terekeci H, Sandal S and Kelestimur F: Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord. 21:127–147. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J and Zoeller RT: Executive summary to EDC-2: The endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 36:593–602. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ and Vom Saal FS: Endocrine-disrupting chemicals and public health protection: A statement of principles from the endocrine society. Endocrinology. 153:4097–4110. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cwiek-Ludwicka K and Ludwicki JK: Endocrine disruptors in food contact materials; is there a health threat? Rocz Panstw Zakl Hig. 65:169–177. 2014.PubMed/NCBI | |
|
La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, Guyton KZ, Kortenkamp A, Cogliano VJ, Woodruff TJ, et al: Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 16:45–57. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Brody JG and Rudel RA: Environmental pollutants and breast cancer. Environ Health Perspect. 111:1007–1019. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Hawke E: Human biomonitoring results reveal widespread exposure of general public to harmful chemicals. https://chemtrust.org/hbm4eu_conference/. Accessed on December 4, 2024. | |
|
Rochester JR and Bolden AL: Bisphenol S and F: A systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect. 123:643–650. 2015.PubMed/NCBI View Article : Google Scholar | |
|
European Food Safety Authority: Bisphenol A | EFSA, 2023. https://www.efsa.europa.eu/en/topics/topic/bisphenol. Accessed on December 11, 2024. | |
|
Liu X, Sakai H, Nishigori M, Suyama K, Nawaji T, Ikeda S, Nishigouchi M, Okada H, Matsushima A, Nose T, et al: Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors. Toxicol Appl Pharmacol. 377(114610)2019.PubMed/NCBI View Article : Google Scholar | |
|
Nadal A, Fuentes E, Ripoll C, Villar-Pazos S, Castellano-Muñoz M, Soriano S, Martinez-Pinna J, Quesada I and Alonso-Magdalena P: Extranuclear-initiated estrogenic actions of endocrine disrupting chemicals: Is there toxicology beyond paracelsus? J Steroid Biochem Mol Biol. 176:16–22. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Cimmino I, Oriente F, D'Esposito V, Liguoro D, Liguoro P, Ambrosio MR, Cabaro S, D'Andrea F, Beguinot F, Formisano P and Valentino R: Low-dose bisphenol-A regulates inflammatory cytokines through GPR30 in mammary adipose cells. J Mol Endocrinol. 63:273–283. 2019.PubMed/NCBI View Article : Google Scholar | |
|
European Union: Comission Regulation (EU) 2016/2235, 2016. https://eur-lex.europa.eu/eli/reg/2016/2235/oj/eng. Accessed on December 13, 2024. | |
|
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Lambré C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, et al: Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 21(e06857)2023.PubMed/NCBI View Article : Google Scholar | |
|
European Commision: Internal Market, Industry, Entrepreneurship and Smes-Bisphenol A: EU ban on use in baby bottles. https://ec.europa.eu/newsroom/growth/items/44933/en. Accessed on December 4, 2024. | |
|
European Commission: European Commission-Daily News, 2024. https://ec.europa.eu/commission/presscorner/api/files/document/print/en/mex_24_3243/MEX_24_3243_EN.pdf. Accessed on December 11, 2024. | |
|
U.S. Environmental Protection Agency: Bisphenol A. (CASRN 80-05-7) | IRIS | US EPA. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0356_summary.pdf. Accessed on December 4, 2024. | |
|
U.S. Food and Drug Administration (FDA): Bisphenol A (BPA) | FDA. FDA, Silver Spring, MD, 2023. https://www.fda.gov/food/food-packaging-other-substances-come-contact-food-information-consumers/bisphenol-bpa. Accessed on December 4, 2024. | |
|
European Chemicals Agency (ECHA): Assessment of regulatory needs. ECHA, Helsinki, 2021. https://echa.europa.eu/documents/10162/7de6871f-30db-9cdc-0a13-20942f511e00. Accessed on December 11, 2024. | |
|
Atlas E and Dimitrova V: Bisphenol S and Bisphenol A disrupt morphogenesis of MCF-12A human mammary epithelial cells. Sci Rep. 9(16005)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim JY, Choi HG, Lee HM, Lee GA, Hwang KA and Choi KC: Effects of bisphenol compounds on the growth and epithelial mesenchymal transition of MCF-7 CV human breast cancer cells. J Biomed Res. 31(358)2017.PubMed/NCBI View Article : Google Scholar | |
|
Winkler J, Liu P, Phong K, Hinrichs JH, Ataii N, Williams K, Hadler-Olsen E, Samson S, Gartner ZJ, Fisher S and Werb Z: Bisphenol A replacement chemicals, BPF and BPS, induce protumorigenic changes in human mammary gland organoid morphology and proteome. Proc Natl Acad Sci USA. 119(e2115308119)2022.PubMed/NCBI View Article : Google Scholar | |
|
Mesnage R, Phedonos A, Arno M, Balu S, Corton JC and Antoniou MN: Editor's highlight: Transcriptome profiling reveals bisphenol A alternatives activate estrogen receptor alpha in human breast cancer cells. Toxicol Sci. 158:431–443. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yamasaki K, Noda S, Imatanaka N and Yakabe Y: Comparative study of the uterotrophic potency of 14 chemicals in a uterotrophic assay and their receptor-binding affinity. Toxicol Lett. 146:111–120. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Stroheker T, Chagnon MC, Pinnert MF, Berges R and Canivenc-Lavier MC: Estrogenic effects of food wrap packaging xenoestrogens and flavonoids in female Wistar rats: A comparative study. Reprod Toxicol. 17:421–432. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Ji K, Hong S, Kho Y and Choi K: Effects of bisphenol S exposure on endocrine functions and reproduction of zebrafish. Environ Sci Technol. 47:8793–8800. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Darbre PD: Endocrine disrupting chemicals and breast cancer cells. Adv Pharmacol. 92:485–520. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wan MLY, Co VA and El-Nezami H: Endocrine disrupting chemicals and breast cancer: A systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 62:6549–6576. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Vandenberg LN: Endocrine disrupting chemicals and the mammary gland. Adv Pharmacol. 92:237–277. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Avagliano A, Granato G, Ruocco MR, Romano V, Belviso I, Carfora A, Montagnani S and Arcucci A: Metabolic reprogramming of cancer associated fibroblasts: The slavery of stromal fibroblasts. Biomed Res Int. 2018(6075403)2018.PubMed/NCBI View Article : Google Scholar | |
|
Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC and Chung LW: Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA. 87:75–79. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Bissell MJ, Rizki A and Mian IS: Tissue architecture: The ultimate regulator of breast epithelial function. Curr Opin Cell Biol. 15:753–762. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Kuziel G, Moore BN and Arendt LM: Obesity and fibrosis: Setting the stage for breast cancer. Cancers (Basel). 15(2929)2023.PubMed/NCBI View Article : Google Scholar | |
|
Ye F, Liang Y, Wang Y, Le Yang R, Luo D, Li Y, Jin Y, Han D, Chen B, Zhao W, et al: Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication. Cell Death Dis. 14(471)2023.PubMed/NCBI View Article : Google Scholar | |
|
Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, Zhuo W, Hu Y, Chen C, Chen L, et al: Cancer-associated fibroblasts in breast cancer: Challenges and opportunities. Cancer Commun (Lond). 42:401–434. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Archer M, Dasari P, Walsh D, Britt KL, Evdokiou A and Ingman WV: Immune regulation of mammary fibroblasts and the impact of mammographic density. J Clin Med. 11(799)2022.PubMed/NCBI View Article : Google Scholar | |
|
Unsworth A, Anderson R and Britt K: Stromal fibroblasts and the immune microenvironment: Partners in mammary gland biology and pathology? J Mammary Gland Biol Neoplasia. 19:169–182. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Thurfjell E: Breast density and the risk of breast cancer. N Engl J Med. 347(866)2002.PubMed/NCBI View Article : Google Scholar | |
|
McCormack VA and dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 15:1159–1169. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hu Y, Zhang L, Wu X, Hou L, Li Z, Ju J, Li Q, Qin W, Li J, Zhang Q, et al: Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway. Toxicol Lett. 250-251:1–9. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Aiello Bowles EJ, Sisney GS and Burnside ES: Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res. 15(R45)2013.PubMed/NCBI View Article : Google Scholar | |
|
Schedin P and Keely PJ: Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 3(a003228)2011.PubMed/NCBI View Article : Google Scholar | |
|
Koledova Z, Zhang X, Streuli C, Clarke RB, Klein OD, Werb Z and Lu P: SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling. Proc Natl Acad Sci USA. 113:E5731–E5740. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C and Maggiolini M: Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 120:1177–1182. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wormsbaecher C, Hindman AR, Avendano A, Cortes-Medina M, Jones CE, Bushman A, Onua L, Kovalchin CE, Murphy AR, Helber HL, et al: In utero estrogenic endocrine disruption alters the stroma to increase extracellular matrix density and mammary gland stiffness. Breast Cancer Res. 22(41)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wadia PR, Cabaton NJ, Borrero MD, Rubin BS, Sonnenschein C, Shioda T and Soto AM: Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland. PLoS One. 8(e63902)2013.PubMed/NCBI View Article : Google Scholar | |
|
Hyun M, Rathor L, Kim HJ, McElroy T, Hwang KH, Wohlgemuth S, Curry S, Xiao R, Leeuwenburgh C, Heo JD and Han SM: Comparative toxicities of BPA, BPS, BPF, and TMBPF in the nematode Caenorhabditis elegans and mammalian fibroblast cells. Toxicology. 461(152924)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim JY, Shin GS, Kim CH, Kim MJ, An MJ, Lee HM and Kim JW: The cytotoxic effects of bisphenol A alternatives in human lung fibroblast MRC5 cells. Mol Cell Toxicol. 17:267–276. 2021. | |
|
Li Q and Spalding KL: The regulation of adipocyte growth in white adipose tissue. Front Cell Dev Biol. 10(1003219)2022.PubMed/NCBI View Article : Google Scholar | |
|
Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, et al: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer. NPJ Breast Cancer. 3(19)2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang M, Chen M, Wang J, Xu M, Sun J, Ding L, Lv X, Ma Q, Bi Y, Liu R, et al: Bisphenol A promotes adiposity and inflammation in a nonmonotonic dose-response way in 5-week-old male and female C57BL/6J mice fed a low-calorie diet. Endocrinology. 157:2333–2345. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F and Pasqualini JR: Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol. 72:23–27. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Humphries MP, Jordan VC and Speirs V: Obesity and male breast cancer: Provocative parallels? BMC Med. 13(134)2015.PubMed/NCBI View Article : Google Scholar | |
|
Hu Y, Liu L, Chen Y, Zhang X, Zhou H, Hu S, Li X, Li M, Li J, Cheng S, et al: Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. Nat Commun. 14(5179)2023.PubMed/NCBI View Article : Google Scholar | |
|
Gao Y, Chen X, He Q, Gimple RC, Liao Y, Wang L, Wu R, Xie Q, Rich JN, Shen K and Yuan Z: Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin. Proc Natl Acad Sci USA. 117:33295–33304. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Q, Zhu Y, Hepler C, Zhang Q, Park J, Gliniak C, Henry GH, Crewe C, Bu D, Zhang Z, et al: Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep. 40(111362)2022.PubMed/NCBI View Article : Google Scholar | |
|
Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71:2455–2465. 2011.PubMed/NCBI View Article : Google Scholar | |
|
De Palma M, Biziato D and Petrova TV: Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 17:457–474. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Fujisaki K, Fujimoto H, Sangai T, Nagashima T, Sakakibara M, Shiina N, Kuroda M, Aoyagi Y and Miyazaki M: Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. Breast Cancer Res Treat. 150:255–263. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Todorović-Raković N and Milovanović J: Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 33:563–570. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Williams GP and Darbre PD: Low-dose environmental endocrine disruptors, increase aromatase activity, estradiol biosynthesis and cell proliferation in human breast cells. Mol Cell Endocrinol. 486:55–64. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Linehan C, Gupta S, Samali A and O'Connor L: Bisphenol A-mediated suppression of LPL gene expression inhibits triglyceride accumulation during adipogenic differentiation of human adult stem cells. PLoS One. 7(e36109)2012.PubMed/NCBI View Article : Google Scholar | |
|
Ahmed F, Sarsenbayeva A, Katsogiannos P, Aguer C and Pereira MJ: The effects of bisphenol A and bisphenol S on adipokine expression and glucose metabolism in human adipose tissue. Toxicology. 445(152600)2020.PubMed/NCBI View Article : Google Scholar | |
|
Masuno H, Iwanami J, Kidani T, Sakayama K and Honda K: Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci. 84:319–327. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Sargis RM, Johnson DN, Choudhury RA and Brady MJ: Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring). 18:1283–1288. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Ohlstein JF, Strong AL, McLachlan JA, Gimble JM, Burow ME and Bunnell BA: Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. J Mol Endocrinol. 53:345–353. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ahmed S and Atlas E: Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int J Obes (Lond). 40:1566–1573. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Salehpour A, Shidfar F, Hedayati M, Neshatbini Tehrani A, Farshad AA and Mohammadi S: Bisphenol A enhances adipogenic signaling pathways in human mesenchymal stem cells. Genes Environ. 42(13)2020.PubMed/NCBI View Article : Google Scholar | |
|
Cohen IC, Cohenour ER, Harnett KG and Schuh SM: BPA, BPAF and TMBPF alter adipogenesis and fat accumulation in human mesenchymal stem cells, with implications for obesity. Int J Mol Sci. 22(5363)2021.PubMed/NCBI View Article : Google Scholar | |
|
Pham DV and Park PH: Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. J Exp Clin Cancer Res. 41(9)2022.PubMed/NCBI View Article : Google Scholar | |
|
Kim Y and Park CW: Mechanisms of adiponectin action: Implication of adiponectin receptor agonism in diabetic kidney disease. Int J Mol Sci. 20(1782)2019.PubMed/NCBI View Article : Google Scholar | |
|
Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW and Ben-Jonathan N: Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect. 116:1642–1647. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lim S, Bae JH, Chun EJ, Kim H, Kim SY, Kim KM, Choi SH, Park KS, Florez JC and Jang HC: Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 51:739–748. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kimata K, Sakakura T, Inaguma Y, Kato M and Nishizuka Y: Participation of two different mesenchymes in the developing mouse mammary gland: Synthesis of basement membrane components by fat pad precursor cells. J Embryol Exp Morphol. 89:243–257. 1985.PubMed/NCBI | |
|
Miyawaki J, Sakayama K, Kato H, Yamamoto H and Masuno H: Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb. 14:245–252. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS and Soto AM: Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 148:116–127. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Munoz-de-Toro M, Markey C, Wadia PR, Luque EH, Rubin BS, Sonnenschein C and Soto AM: Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology. 146:4138–4147. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Ramskov Tetzlaff CN, Svingen T, Vinggaard AM, Rosenmai AK and Taxvig C: Bisphenols B, E, F, and S and 4-cumylphenol induce lipid accumulation in mouse adipocytes similarly to bisphenol A. Environ Toxicol. 35:543–552. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Frühbeck G, Méndez-Giménez L, Fernández-Formoso JA, Fernández S and Rodríguez A: Regulation of adipocyte lipolysis. Nutr Res Rev. 27:63–93. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Martínez M, Blanco J, Rovira J, Kumar V, Domingo JL and Schuhmacher M: Bisphenol A analogues (BPS and BPF) present a greater obesogenic capacity in 3T3-L1 cell line. Food Chem Toxicol. 140(111298)2020.PubMed/NCBI View Article : Google Scholar | |
|
Drobna Z, Talarovicova A, Schrader HE, Fennell TR, Snyder RW and Rissman EF: Bisphenol F has different effects on preadipocytes differentiation and weight gain in adult mice as compared with Bisphenol A and S. Toxicology. 420:66–72. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chernis N, Masschelin P, Cox AR and Hartig SM: Bisphenol AF promotes inflammation in human white adipocytes. Am J Physiol Cell Physiol. 318:C63–C72. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Leon-Ferre RA, Jonas SF, Salgado R, Loi S, de Jong V, Carter JM, Nielsen TO, Leung S, Riaz N, Chia S, et al: Tumor-infiltrating lymphocytes in triple-negative breast cancer. JAMA. 331:1135–1144. 2024.PubMed/NCBI View Article : Google Scholar | |
|
Valenza C, Taurelli Salimbeni B, Santoro C, Trapani D, Antonarelli G and Curigliano G: Tumor infiltrating lymphocytes across breast cancer subtypes: Current Issues for biomarker assessment. Cancers (Basel). 15(767)2023.PubMed/NCBI View Article : Google Scholar | |
|
Qiu SQ, Waaijer SJH, Zwager MC, de Vries EGE, van der Vegt B and Schröder CP: Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treat Rev. 70:178–189. 2018.PubMed/NCBI View Article : Google Scholar | |
|
No authors listed. Estrogen receptor-positive breast cancer subtypes show differential macrophage functions. Nat Cancer. 4:450–451. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Tran HTT, Herz C and Lamy E: Long-term exposure to ‘low-dose’ bisphenol A decreases mitochondrial DNA copy number, and accelerates telomere shortening in human CD8 + T cells. Sci Rep. 10(15786)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kim H, Kim HS and Moon WK: Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 385(114814)2019.PubMed/NCBI View Article : Google Scholar | |
|
Bouzidi L, Triki H, Charfi S, Kridis WB, Derbel M, Ayadi L, Sellami-Boudawara T and Cherif B: Prognostic value of natural killer cells besides tumor-infiltrating lymphocytes in breast cancer tissues. Clin Breast Cancer. 21:e738–e747. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim IS, Gao Y, Welte T, Wang H, Liu J, Janghorban M, Sheng K, Niu Y, Goldstein A, Zhao N, et al: Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 21:1113–1126. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Balistrieri A, Hobohm L, Srivastava T, Meier A and Corriden R: Alterations in human neutrophil function caused by bisphenol A. Am J Physiol Cell Physiol. 315:C636–C642. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chanmee T, Ontong P, Konno K and Itano N: Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 6:1670–1690. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Palacios-Arreola MI, Nava-Castro KE, Río-Araiza VHD, Pérez-Sánchez NY and Morales-Montor J: A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood. Sci Rep. 7(10573)2017.PubMed/NCBI View Article : Google Scholar | |
|
Kim H, Kim HS, Piao YJ and Moon WK: Bisphenol A promotes the invasive and metastatic potential of ductal carcinoma in situ and protumorigenic polarization of macrophages. Toxicol Sci. 170:283–295. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Pahović PŠ, Iulini M, Maddalon A, Galbiati V, Buoso E, Dolenc MS and Corsini E: In vitro effects of bisphenol analogs on immune cells activation and Th differentiation. Endocr Metab Immune Disord Drug Targets. 23:1750–1761. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Oshi M, Gandhi S, Yan L, Tokumaru Y, Wu R, Yamada A, Matsuyama R, Endo I and Takabe K: Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast Cancer Res Treat. 194:231–241. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Qiu W, Shao H, Lei P, Zheng C, Qiu C, Yang M and Zheng Y: Immunotoxicity of bisphenol S and F are similar to that of bisphenol A during zebrafish early development. Chemosphere. 194:1–8. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Dontu G and Ince TA: Of mice and women: A comparative tissue biology perspective of breast stem cells and differentiation. J Mammary Gland Biol Neoplasia. 20:51–62. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cardiff RD and Wellings SR: The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia. 4:105–122. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Roberts GC, Morris PG, Moss MA, Maltby SL, Palmer CA, Nash CE, Smart E, Holliday DL and Speirs V: An evaluation of matrix-containing and humanised matrix-free 3-dimensional cell culture systems for studying breast cancer. PLoS One. 11(e0157004)2016.PubMed/NCBI View Article : Google Scholar | |
|
Russo J and Russo IH: Genotoxicity of steroidal estrogens. Trends Endocrinol Metab. 15:211–214. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Sachs N and Clevers H: Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev. 24:68–73. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Reddington R, Galer M, Hagedorn A, Liu P, Barrack S, Husain E, Sharma R, Speirs V and Masannat Y: Incidence of male breast cancer in Scotland over a twenty-five-year period (1992-2017). Eur J Surg Oncol. 46:1546–1550. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Roberts S, Peyman S and Speirs V: Current and emerging 3D models to study breast cancer. Adv Exp Med Biol. 1152:413–427. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Weigelt B, Ghajar CM and Bissell MJ: The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev. 69-70:42–51. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Tang M, Jiang S, Huang X, Ji C, Gu Y, Qi Y, Xiang Y, Yao E, Zhang N, Berman E, et al: Integration of 3D bioprinting and multi-algorithm machine learning identified glioma susceptibilities and microenvironment characteristics. Cell Discov. 10(39)2024.PubMed/NCBI View Article : Google Scholar | |
|
Huh D, Hamilton GA and Ingber DE: From 3D cell culture to organs-on-chips. Trends Cell Biol. 21:745–754. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ståhl PL, Salmén F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, Giacomello S, Asp M, Westholm JO, Huss M, et al: Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 353:78–82. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Reed AD, Pensa S, Steif A, Stenning J, Kunz DJ, Porter LJ, Hua K, He P, Twigger AJ, Siu AJQ, et al: A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast. Nat Genet. 56:652–662. 2024.PubMed/NCBI View Article : Google Scholar | |
|
EFSA Panel on Food Contact Materials, Enzymes Flavourings and Processing Aids (CEF). Scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 13(3978)2015. | |
|
Dueñas-Moreno J, Mora A, Kumar M, Meng XZ and Mahlknecht J: Worldwide risk assessment of phthalates and bisphenol A in humans: The need for updating guidelines. Environ Int. 181(108294)2023.PubMed/NCBI View Article : Google Scholar |
